Delivery Order SPE2DB22D3004-SPE2DB25FPJ74
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D3103|SPE2DB24FP1M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,771.23 firm fixed-price delivery order is for the supply of 4,564,884,036 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
This federal contract award, valued at $7,915.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, in quantities of 30 tablets per order. The contract has a completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen...
This federal contract award, valued at $37,962.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, to support DLA's medical supply requirements. The contract has an ultimate completion date of November 29, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was...
This federal contract award, with a ceiling value of $16,610.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg Tablets, a medication commonly used to treat nausea and vomiting, and has an ultimate completion date of November 21, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,703.06 firm fixed-price delivery order is for the supply of 4,564,997,915 units of the medication Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has a completion date of June 26, 2024 and was awarded on June 25, 2024. This delivery order is part of a larger $999,999,999...
This federal contract award, valued at $1,871.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of November 22, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating...
This federal contract award, valued at $9,466.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of September 25,...
This federal contract award, valued at $22,249.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,821.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,457,120 units of the drug Ondansetron ODT 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of March 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,978.01, is for the delivery of Ondansetron ODT 4 mg tablets. This is a firm fixed-price delivery order contract with a completion date of January 22, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...